Product Transference Study of Testagen™ TDS®-Testosterone

NCT02733133 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypogonadotropism

Interventions

DRUG: Testagen® TDS Testosterone 5% HypoSpray®

Sponsor

Transdermal Delivery Solutions Corp

Collaborators

[object Object]